Materials and methods: Lung tissue specimens from 50 patients who underwent surgery for NSCLC (stages I-III) and 10 control group subjects were analyzed immunohistochemically.
Results: NSCLC patients had a greater number of CD4 + and CD8 + T cells infiltrating the lung tissue than the control group (P = 0.001) with predominant infiltration in the tumor stroma.
We found a significant association between the number of total and tumor stroma-infiltrating CD4 + and CD8 + T cells, and smoking status (P < 0.05).
There were more CD8 + T cells in the tumor stroma and fewer in the tumor islets in NSCLC patients with COPD as compared to NSCLC patients without COPD (P < 0.05). However, there was no such association between CD4 + T cells and COPD status. A high level of CD8 + T cell infiltration in the tumor stroma was independently associated with the coexistence of COPD in multivariate analysis (P < 0.05).
Conclusions: According to our data, COPD but not smoking seems to be associated with higher infiltration of CD8 + T cells in the tumor stroma of patients with NSCLC. It allows us to
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Introduction
Lung cancer and chronic obstructive pulmonary disease (COPD) are the leading causes of morbidity and mortality worldwide [1] . The association between COPD and lung cancer has been reported in numerous studies [2] . COPD and lung cancer are disorders characterized by an abnormal local and systemic inflammatory response with smoking being as a major environmental risk factor [3] . Tobacco smoke stimulates both local and systemic inflammation, which may play a crucial role in both lung cancer and COPD. On the other hand, COPD has been reported to be a risk factor for lung cancer despite the smoking status [4, 5] . The annual incidence of lung cancer arising from COPD has been reported to be 0.8%-1.7% [6, 7] . Coexistence of COPD and lung cancer has an impact on the disease course and the outcome of cancer patients with conflicting results being reported [8] .
The mechanisms by which COPD increases the risk of development of lung cancer and the influence of COPD on the prognosis of patients with lung cancer are not clear although it is accepted that chronic immune inflammation probably plays a role in the pathogenesis of lung cancer in these patients. Chronic inflammation is associated with malignant transformation and an increased incidence of local cancer in such a way how reflux esophagitis is associated with esophageal carcinoma; Helicobacter pylori gastric inflammation, with stomach cancer; viral hepatitis, with liver cancer; and inflammatory bowel diseases (chronic ulcerative colitis and Crohn's disease), with colon carcinoma [9] [10] [11] . The inflammatory responses that characterize COPD drive a repetitive cycle of injury and repair throughout the lungs with ongoing recruitment of host inflammatory cells and increase the risk of transformation of normal bronchial epithelium to a malignant phenotype [12, 13] . Macrophages, neutrophils, and lymphocytes are the main players in chronic immune inflammation in COPD as well as lung cancer. In both airway and alveolar compartments, the CD8 + cytotoxic T cell is the predominant T cell in patients with COPD. The number of pulmonary CD8 + T cells in COPD increases substantially with higher stages of airflow limitation and emphysema. Smokers with COPD have increased numbers of CD4 + T cells in the airways and lungs [14, 15] . In lung cancer, the essential role in the immune response to cancer cells is played by tumor-infiltrating CD4 + and CD8 + T cells [16, 17] . CD8 + T cells represent a major arm of the antitumor response because they have cytotoxic cell-mediated activity toward tumor cells expressing tumor-associated antigens [18] . It is thought that CD4 + T cells also play a significant role in antitumor response by allowing CD8 + T cells to entry into the tumor site [19] and infected mucosa [20] , and they also are required for angiogenesis inhibition at the tumor site [21] . Contradictory data have been published about the influence of the different infiltration patterns of immune cells in lung cancer on the prognosis of these patients [11] . Nevertheless, the data about the importance of accumulation and distribution patterns of CD4 + and CD8 + T cells in the lungs of patients with lung cancer in the background of chronic inflammation due to COPD are scarce. Coexistence of lung cancer and COPD could influence the functions of these cells considerably by promoting or suppressing tumor growth depending on the status of the lung immune [22] . Based on previous data on the link between COPD and nonsmall cell lung cancer (NSCLC), we aimed to evaluate the infiltration patterns of CD4 + Written informed consent was obtained from all study subjects.
Immunohistochemical analysis
Lung tissue samples were fixed in formalin and, after dehydration, embedded in paraffin. Tissue sections 3-to 5-mm thick were cut, subsequently de-waxed and rehydrated through graded alcohols. Slides immunohistochemically analyzed for the expression of CD4 + and CD8 + T cells. A Roche Ventana
Benchmark XT automated slide stainer (Ventana Medical Systems, Roche, France) was used for immunohistochemistry.
Immunohistochemical staining was performed according to the manufacturer's instructions. Monoclonal rabbit anti human antibodies were used for identification of CD4 + T cells (anti-CD4, SP35, Ventana) and CD8 + T cells (anti-CD8, SP57, Ventana).
Quantitative evaluation of CD4 + and CD8 + T cells was done in 5 most representative high-power fields (HPFs 400Â magnification) per tissue section using an Olympus BX50 microscope (Olympus Co, Japan). The number of cells with positive staining was counted manually in two locations: tumor stroma and tumor islets ( Fig. 1 ). Slides were coded, and microscopic analysis was carried out blindly to the clinical data.
Statistical analysis
All statistical analyses were performed using the Statistical Package for the Social Sciences (SPSS), version 20.0. 
Results
Demographic, clinical, and histological characteristics of studied subjects are shown in There was no association between the numbers of total CD4 + or CD8 + T cells in tumor stroma or islets and NSCLC patients' gender, age, pathological T status, lymph node status, or tumor differentiation (Tables 2 and 3) . While analyzing the total number of CD4 + T cells, they were more frequently found in squamous cell carcinoma than adenocarcinoma (P = 0.04) ( and 4). Significantly higher amount of total tumor infiltrating CD4 + and CD8 + T cells was found in smoking NSCLC patients compared to non-smokers NSCLC patients (P = 0.03) ( Table 2 ). Our data showed that there were significantly more smokers with NSCLC having a high level of CD4 + and CD8 + T cell infiltration as compared to nonsmokers with NSCLC (P = 0.02) ( Table 2 ). There were no significant differences in the level of CD4 + or CD8 + T cell infiltration either in the tumor islets or stroma comparing both patients' groups (Table 3) . There were more CD8 + T cells in the tumor stroma in NSCLC patients with COPD compared with NSCLC patients without COPD (P = 0.01). However, the number of CD8 + T cells in the tumor islets was significantly greater in the group of NSCLC patients without COPD than their counterparts with COPD (P = 0.04) (Fig. 5) . The total number of tumor-infiltrating CD4 + and CD8 + T cells did not differ significantly between these groups; however, a trend toward higher numbers of tumorinfiltrating CD8 + T cells in NSCLC patients with COPD was observed (P = 0.06) ( Table 2 ). The high level of CD8 + T cell infiltration in the tumor islets was found more frequently in NSCLC patients without COPD compared to NSCLC patients with COPD, and contrary, the high level of CD8 + T cell infiltration in the tumor stroma was found more frequently in NSCLC patients with COPD compared to NSCLC patients without COPD (P = 0.01 and P = 0.02, respectively) ( Table 3 ). There were no significant differences in the level of CD4 + T cell infiltration either in the tumor islets or 2 0 1 5 ) 2 6 3 -2 7 1 stroma and total CD4 + and CD8 + T cell infiltration between these patients' groups, but there was a trend of higher CD8 + T cell infiltration in NSCLC patients with COPD (P = 0.07) ( Tables 2  and 3 
Discussion
In this study, we aimed to determine if there is an association between the number and infiltration level of CD4 + and CD8 + T cells in tumor stroma or islets and clinicopathological features with special attention given to coexisting COPD and smoking status. Differently from normal tissue, lung tumors have two distinct but interdependent compartments: the parenchyma (neoplastic cells) and the stroma that the neoplastic cells induce and in which they are dispersed, that is why while analyzing control and NSCLC groups we used total number (in tumor islets and stroma) of CD4 + and CD8 + T cells. As expected, the numbers of CD4 + and CD8 + T cells were greater in the NSCLC tissue than the lung tissue from control group subjects.
To the best of our knowledge, there are no studies that compared T cell infiltration in the lung tissue between lung cancer patients and control subjects. In previous reports, reported that expression of all of the activation markers examined was significantly higher in CD4 + and CD8 + T cells from early stage lung cancer as compared with control from healthy donor peripheral blood [29] . Thus, our findings and previous studies support the idea that tumor-associated CD4 + and CD8 + T cells may play an essential role in immune response during oncological process as demonstrated by higher infiltration of these cells and significant state of activation in NSCLC as compared to healthy subjects. Tumor-infiltrating CD4 + and CD8 + T lymphocytes were observed predominantly in the tumor stroma compared to islets. These findings are in agreement with the results from other studies, which found that the number of infiltrating CD4 + or CD8 + T cells in the tumor stroma was overwhelmingly higher than in the tumor islets [16, 30, 31] . It was shown that antitumor cytokines contributing to tumor suppression acted mainly in the stroma [32] . Thus, the abundance of tumorinfiltrating lymphocytes in the tumor stroma let suggest a significant impact of the stromal component on the modulation of cancer cells. On the other hand, in our study, CD8 + T cells predominated over CD4 + T cells in the tumor islets but not in the tumor stroma. Wakabayashi et al. also found that CD8 + T cells predominated over CD4 + T cells in the tumor islets [33] . It is well known that cytotoxic CD8 + T cells are the principal antitumor effector cells that recognize particular tumorassociated antigens presented on MHC class I molecules at the cancer cell surface and possess the ability to destroy cancer cells directly [34] . Previous studies showed that a higher number of epithelial CD8 + T cells were associated with tumor cell apoptosis [35] or IFN-g/CD8 ratio [36] in NSCLC. Our results also suggest that CD8 + T cells could be directly involved in immune response against lung cancer cells in the tumor islets. maintain their proliferation. There are data that CD4 + T cells are required for CD8 + T cell activation against cancer cells by secreting cytokines such as interleukin 2, which is required for the growth and proliferation of CD8 + T cells [16, 27] and their transformation into long-lived functional effector cells [37] . This positive interaction between immune cells was also found in our study as there was significant correlation between the number of CD4 + and CD8 + T cells in different compartments of cancer.
The greater number of total CD4 + T cells was more frequently found in squamous cell carcinoma compared with adenocarcinoma as well as CD4 + and CD8 + T cells were more abundantly found in the stroma of squamous cell carcinoma compared with adenocarcinoma. Hiraoka et al. found that CD8 + T cells in the tumor islets were significantly associated with the histology of squamous cell carcinoma [16] . Wakabayashi et al. reported that CD4 + and CD8 + T cells in the tumor islets or stroma were more frequently found in squamous cell carcinoma compared with adenocarcinoma [33] . The reason for these differences between histology and T cell infiltration could be a difference in immunogenicity of different histological subtype of NSCLC. For example, it was shown that squamous cell carcinoma of the lung had a higher frequency of mutations that adenocarcinoma [38] . These findings suggest that squamous cell carcinoma could be more immunogenic lung cancer than adenocarcinoma. On the other hand, a recent study by Alifano et al. has reported opposite results showing a lower density of infiltrating CD8 + T cells in the tumor islets in squamous cell carcinoma [39] . Cigarette smoking causes lung cancer, poses a greater risk of metastatic cancer spread and increases overall mortality in cancer patients. Smoking is a risk factor for COPD as well. A significantly higher number of total and tumor stromainfiltrating CD4 + and CD8 + T cells as well as a higher level of total CD4 + and CD8 + T cell infiltration in smoking patients compared to nonsmokers with NSCLC were documented in our study. Some studies have reported that the number of CD8 + and CD4 + T cells was greater in the lungs of patients with COPD and even asymptomatic smokers than nonsmoking controls [40] [41] [42] [43] . In one large study, Saetta et al. immunohistochemically examined alveolar walls and pulmonary arteries to identify CD4 + and CD8 + T cells and found that smokers with COPD had an increased number of CD8 + T cells both in lung parenchyma and pulmonary arteries as compared with nonsmokers. The numbers of CD8 + T cells were also increased in pulmonary arteries of smokers with COPD as compared with smokers with normal lung function [44] . Smokers with normal lung function showed increased numbers of macrophages and T lymphocytes in the lung parenchyma compared with control nonsmokers [45] . The number of CD4 + cells was reported not to be changed in patients with mild/moderate COPD compared with control smokers [46] . Contradictory data have been published about the influence of smoking on CD4 + and CD8 + T cells in NSCLC. Some studies found that CD4 + and CD8 + T cells in tumor islets correlated significantly with the smoking habit, i.e., smokers had greater numbers of these cells [33] , while others did not find such associations [31, 39] .
Our results in agreement with other previous studies let suggest that tobacco smoking interferes with the host defense system [47] [48] [49] . It is known that tobacco smoking stimulates the migration of neutrophils, macrophages, CD4 + , CD8 + , and B cell lymphocytes and smaller numbers of dendritic cells and natural killer cells into the damaged tissue [47] . On the other hand, cigarette smoking inhibits the maturation of dendritic cells. Smoke-induced defects in the function of dendritic cells may lead to impaired function of T cells and inhibit tumor immunosurveillance [48] . In mouse models, the activation of CD8 + T cells has been reported to be impaired in the presence of cigarette smoke [49] . Thus, tobacco smoking through chronic inflammation could not only attract more immune cells, but also impair the function of these cells. Smoking, COPD, and lung cancer are closely related because chronic airway inflammation is a key feature of smokinginduced lung damage and play a significant role in the pathogenesis of COPD and lung cancer. However, a direct role of chronic inflammation defined as lung tissue infiltration with T cells in the pathogenesis of lung cancer and its relation to the processes in COPD have not been completely elucidated yet. Regarding specific inflammation, CD4 + helper and especially cytotoxic CD8 + T lymphocytes have been increased in airways and lung parenchyma in COPD patients [40] . Even though the mechanisms by which CD8 + and CD4 + T cells accumulate in the lungs of patients with COPD are not yet understood, it is thought that an increased number of T cells in the lungs are due to adhesion and selective chemotaxis [50] . The excessive recruitment of T cells in the lungs could be a consequence of response to neoantigens induced by cigarette smoke or simply response to viral infections (active or latent) that are common in this disease [40] .
To the best of our knowledge, we are first who presented the data about a significant association of COPD with the patterns of CD4 + and CD8 + T cell infiltration in NSCLC. Our results show that NSCLC patients with COPD had a greater number of CD8 + T cells in the tumor stroma and a lower number in the tumor islets than those without COPD. There was a trend toward higher numbers of total tumor-infiltrating CD8 + T cells in NSCLC patients with COPD as well. Multivariate analysis revealed that a high level of CD8 + T cell infiltration in the tumor stroma was independently associated with the presence of COPD. We found only one study carried out by Alifano et al. that did not report associations between the density of CD8 + T cells in tumor islets and COPD. However, the same investigators reported that the density of intratumoral mature dendritic cells was significantly associated with COPD status in multivariate analysis [39] . These results are in line with our results and suggest that coexisting COPD could influence the accumulation of immune cells in the tumor stroma rather than tumor islets. We suggest that lung cancer developed in COPD patients arises in the lung tissue enriched by CD8 + T cells compared to lung cancer patients without COPD. In addition, smoking increases the total number of CD4 infiltration is a favorable prognostic factor for overall and disease-free survival [16, 30, 33, 52, 53] .
Conclusions
Due to chronic airway inflammation smoking, COPD and lung cancer are closely related. According to our data, COPD but not smoking seems to be associated with greater infiltration of CD8 + T cells in the tumor stroma of patients with NSCLC. It allows us to hypothesize that NSCLC patients with coexisting COPD may have a more favorable outcome due to anticancer properties of stromal CD8 + T cells; however, further investigations are required.
